MBCL-15. IMPACT OF MOLECULAR SUBGROUPS ON OUTCOMES FOLLOWING RADIATION TREATMENT RANDOMIZATIONS FOR AVERAGE RISK MEDULLOBLASTOMA: A PLANNED ANALYSIS OF CHILDREN’S ONCOLOGY GROUP (COG) ACNS0331

The COG conducted a randomized trial for average-risk medulloblastoma (AR-MB). Patients age 3–21 years were randomized to a radiation boost to the whole posterior fossa (PFRT) or an involved field volume (IFRT) after receiving CSI. Patients age 3–7 years were also randomized to standard dose CSI (23...

Descripción completa

Detalles Bibliográficos
Autores principales: Michalski, Jeff, Northcott, Paul, Li, Yimei, Billups, Catherine, Smith, Kyle, Burger, Peter, Merchant, Thomas, Gajjar, Amar, Fitzgerald, T J, Vezina, Gilbert, Fouladi, Maryam, Packer, Roger, Tarbell, Nancy, Janss, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Medulloblastoma (Clinical)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715222/
http://dx.doi.org/10.1093/neuonc/noaa222.491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715222/
http://dx.doi.org/10.1093/neuonc/noaa222.491

Ejemplares similares